Clinical Trial Update: Risk of Bleeding and Anticoagulation in Atrial Fibrillation: What Predictive Criterion Used?

View source ↗

Summary

This clinical trial update examines what predictive criterion is used to assess bleeding risk in patients with atrial fibrillation who are on anticoagulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Atrial Fibrillation, Gerontology | Status: COMPLETED